Chemoimmunotherapy for stage IV non-small-cell lung cancer - Authors' reply.

Saved in:
Bibliographic Details
Title: Chemoimmunotherapy for stage IV non-small-cell lung cancer - Authors' reply.
Authors: Cappuzzo F; Department of Oncology and Hematology, AUSL Romagna, 48100 Ravenna, Italy. Electronic address: federico.cappuzzo@auslromagna.it., West H; Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, USA.
Source: The Lancet. Oncology [Lancet Oncol] 2019 Sep; Vol. 20 (9), pp. e467.
Publication Type: Letter; Comment
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(19)30544-3